Immunohistochemistry of Inflammatory myofibroblastic tumors

AUTHORS

Mohsen Emami Aleagha 1 , Ahmad Faramarzi 2 , * , Sedigheh Khazaei 2 , Sayed Hamid Madani 2 , Rostam Ghorbani 3

1 Dept. of pathology, Kermanshah University of Medical Science, Kermanshah, Iran

2 Dept. of pathology, Molecular Pathology Research Center, Imam Reza Hospital, Kermanshah, Iran

3 Dept.of Anatomy & Histology, Kermanshah University of Medical Science, Kermanshah, Iran

How to Cite: Emami Aleagha M, Faramarzi A, Khazaei S , Madani S H, Ghorbani R. Immunohistochemistry of Inflammatory myofibroblastic tumors, J Kermanshah Univ Med Sci. 2009 ; 13(3):e79599.

ARTICLE INFORMATION

Journal of Kermanshah University of Medical Sciences: 13 (3); e79599
Published Online: December 19, 2009
Article Type: Research Article
Received: April 09, 2009
Accepted: September 08, 2009

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: Inflammatory myofibroblastic tumor (IMT) or inflammatory pseudotumor is a tumoral lesion which can be seen in all age groups and in all internal organs. It is in  differential diagnosis with some important neoplasms such as Leiomyosarcoma, Rhabdomyosarcoma, and Sarcomatoid carcinoma.  Differentiation between these tumors requires a special diagnostic tool such as Immunohistochemistry (IHC). This study aimed to identify Immunohistochemical characteristics of  inflammatory myofibroblastic tumors.

Methods: 19 cases included in this cross-sectional study. All cases with diagnosis  of :" Inflammatory myofibroblastic tumor" or " Inflammatory pseudotumor" at pathobiology laboratories of Kermanshah university, Tehran Imam Khomaini Hospital and Institute of Cancer were selected and studied by using IHC stains   for CK, EMA, SMA, MSA, Desmin, P53, ALK and Vimentin .

Results: Mean age of cases was 40.4 year . 52.6% were male and 47.4% female. Most frequent affected organs were; Stomach (4 cases), Urinary Bladder (3 cases), Small Intestine (3 cases), Lung and Mediastinum (3cases), Omentum (2 cases), Retroperitoneum (1 case), Cervix(1 case), Urethra(1 case) and gluteus Maximus Muscle (1 case), . Vimentin (94.7%) , MSA (57.9%) and SMA (47.4%) were the most frequent expressed IHC biomarkers in diagnosed tumors  respectively.

Conclusion: CK is a reliable marker for differentiation between these lesions and Sarcomatoid carcinoma. For differentiation from Leiomyosarcoma, Rhabdomyosarcoma and Postoperative Spindle Cell Nodule, using Desmin is a useful biomarker. It is recommended that "IMT"  be used for those lesions that express ALK and/or those that cytogenetic studies reveal a fusion of introducing genes. Other lesions should be classified and reported as "Inflammatory Pseudotumor.

Keywords

Inflammatory myofibroblastic tumor IMT IHC ALK

© 2009, Journal of Kermanshah University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Fulltext

References

  • 1.

    The references of this article is available on PDF

  • COMMENTS

    LEAVE A COMMENT HERE: